[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353904-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353904-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-cell-derived-sialylated-igg-interacting-with-siglec-7910-is-a-potential-immunotherapeutic-target-in-pancreatic-cancer","Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer","","The limited effectiveness of T cell-based immune checkpoint blockade in pancreatic ductal adenocarcinoma (PDAC) is linked to poor CD8+ T cell infiltration and an immunosuppressive tumor microenvironment driven by excessive myeloid accumulation. The study identifies cancer cell-derived sialylated IgG (SIA-IgG) as a pro-cancer factor overexpressed in PDAC cells. SIA-IgG inhibits macrophage phagocytosis, induces an M2-like phenotype via Siglec-7/9/10, and amplifies suppression through a SIA-IgG–TGF-β1 positive feedback loop. Blocking SIA-IgG with monoclonal antibodies reverses immunosuppressive microenvironment features, highlighting the SIA-IgG/Siglec axis as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-cell-derived-sialylated-igg-interacting-with-siglec-7910-is-a-potential-immunotherapeutic-target-in-pancreatic-cancer/353904/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-cell-derived-sialylated-igg-interacting-with-siglec-7910-is-a-potential-immunotherapeutic-target-in-pancreatic-cancer/353904.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in PDAC immunotherapy?","Question",{"text":63,"@type":64},"It addresses the limited efficacy of T cell-based immune checkpoint blockade in most patients with PDAC, attributed to poor CD8+ T cell infiltration and a highly immunosuppressive microenvironment driven by myeloid accumulation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SIA-IgG influence macrophages in PDAC?",{"text":68,"@type":64},"SIA-IgG inhibits macrophage phagocytosis and induces an M2-like immunosuppressive phenotype through interactions with Siglec-7/9/10.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the role of the SIA-IgG and TGF-β1 feedback loop?",{"text":72,"@type":64},"SIA-IgG and TGF-β1 reinforce each other in a positive feedback loop, amplifying immune suppression and promoting immune evasion in PDAC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353904,1790147453,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nCancer cell-derived sialylated IgG interacting with Siglec- 7/9/10 is a potential immunotherapeutic target in pancreatic cancer  \nGraphical abstract  \nHighlights  \n• SIA-IgG is highly expressed in PDAC and promotes immune evasion  \nAuthors  \nShenghua Zhang, Ming Cui,  \nXinmei Huang, ..., Quan Liao, Yupei Zhao, Xiaoyan Qiu  \nCorrespondence  \n[cuiming@pumch.cn](cuiming@pumch.cn) (M.C.),  \n[zhao8028@263.net](zhao8028@263.net) (Y.Z.),  \n[qiuxy@bjmu.edu.cn](qiuxy@bjmu.edu.cn) (X.Q.)  \nIn brief  \nZhang et al. identify cancer cell-derived sialylated IgG as a driver of macrophagemediated immune suppression in PDAC. Targeting SIA-IgG remodels the tumor microenvironment and reveals a potential immunotherapeutic strategy.  \n• SIA-IgG functions as a ligand for Siglec-7/9/10 to drive M2 macrophage polarization  \n• A positive feedback loop between SIA-IgG and TGF-β1 amplifies immune suppression  \n• Targeting SIA-IgG remodels the immunosuppressive tumor microenvironment in PDAC  \nZhang et al., 2026, Cell Reports Medicine 7, 102660  \nMarch 17, 2026 © 2026 The Authors. Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2026.102660](https://doi.org/10.1016/j.xcrm.2026.102660)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nCancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer  \nShenghua Zhang,1,2,9 Ming Cui,3,4,5,6,9,* Xinmei Huang,1,2,8 Xiaoyao Feng,1,2 Ruiling Xiao,3,4,5,6 Qijia Liu,1,2 Jialu Bai,3,4,5,6 Xianlin Han,3,4,5,6 Xiaoding Liu,6,7 Weiyan Xu,1,2 Jing Huang,1,2 Quan Liao,3,4,5,6 Yupei Zhao,3,4,5,6,* and Xiaoyan Qiu1,2,10,*  \n1Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing 100191, China  \n2NHC Key Laboratory of Medical Immunology, Peking University, Beijing 100191, China  \n3Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China  \n4Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China  \n5National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China  \n6State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China  \n7Research Center for Molecular Pathology, Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China  \n8Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing 210031, China  \n9These authors contributed equally  \n10Lead contact  \n*Correspondence: [cuiming@pumch.cn](cuiming@pumch.cn) (M.C.), [zhao8028@263.net](zhao8028@263.net) (Y.Z.), [qiuxy@bjmu.edu.cn](qiuxy@bjmu.edu.cn) (X.Q.) [https://doi.org/10.1016/j.xcrm.2026.102660](https://doi.org/10.1016/j.xcrm.2026.102660)  \nSUMMARY  \nThe limited effectiveness of T cell-based immune checkpoint blockade (ICB) therapy in most patients with pancreatic ductal adenocarcinoma (PDAC) is largely due to poor CD8+ T cell infiltration and a highly immunosuppressive microenvironment driven by excessive myeloid cell accumulation. This highlights the urgent need for new immunotherapy targets and strategies. In this study, an identified pro-cancer factor, cancer cell-derived sialylated IgG (SIA-IgG), is found to be significantly overexpressed in pancreatic cancer cells. SIA-IgG inhibits macrophage phagocytosis and induces an M2-like immunosuppressive phenotype through interactions with Siglec-7/9/10 . SIA-IgG and TGF-β1, a key immunosuppressive factor, reinforce each other in a positive feedback loop, promoting immune evasion in PDAC. Blocking SIA-IgG with ","cbCaieYyB74yexzW","https://ap.wps.com/l/cbCaieYyB74yexzW","pdf",16188520,26,"English","# Highlights\n# In brief\n# Summary\n# Introduction","[{\"question\":\"What problem does the study address in PDAC immunotherapy?\",\"answer\":\"It addresses the limited efficacy of T cell-based immune checkpoint blockade in most patients with PDAC, attributed to poor CD8+ T cell infiltration and a highly immunosuppressive microenvironment driven by myeloid accumulation.\"},{\"question\":\"How does SIA-IgG influence macrophages in PDAC?\",\"answer\":\"SIA-IgG inhibits macrophage phagocytosis and induces an M2-like immunosuppressive phenotype through interactions with Siglec-7/9/10.\"},{\"question\":\"What is the role of the SIA-IgG and TGF-β1 feedback loop?\",\"answer\":\"SIA-IgG and TGF-β1 reinforce each other in a positive feedback loop, amplifying immune suppression and promoting immune evasion in PDAC.\"}]","Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer | PDF",1790107857,66,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a883185c792039b1ffb65514c8acef7c.webp",983,1276,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/072be55b4edcd2eea0c47ce8e96b8dfe.webp",982,1275,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/140374e70bce96e80efd294a8bfc3685.webp",981,1273,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ed4daa7e201f48e2bc560e3d94c1577.webp",980,1272]